BIOMERICA INC

BMRA · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances
193
SEC Filings

Business Summary

Biomerica is a global biomedical technology company that develops, manufactures, and markets diagnostic test kits and therapeutic products. Its products analyze blood, urine, nasal, or fecal samples to diagnose diseases, food intolerances, and other conditions. Key products include inFoods IBS, a diagnostic-guided therapy using a blood test to identify IBS-triggering foods, and hp+detect, an FDA-cleared test for detecting Helicobacter pylori. Products are sold worldwide to clinical laboratories and point-of-care settings.

Next Earnings

Q2 FY2026 — expected 2026-09-23

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBMRAdiscussed_in_filing Artificial Intelligence
topic_mentionBMRAdiscussed_in_filing Cybersecurity
topic_mentionBMRAdiscussed_in_filing Trusted Computing
topic_mentionBMRAdiscussed_in_filing Blockchain & Crypto
topic_mentionBMRAdiscussed_in_filing Supply Chain
topic_mentionBMRAdiscussed_in_filing Regulation
topic_mentionBMRAdiscussed_in_filing Healthcare & Bio
topic_mentionBMRAdiscussed_in_filing AI Compute
topic_mentionBMRAdiscussed_in_filing Platform & Ecosystem
topic_mentionBMRAdiscussed_in_filing Sovereign & Government
topic_mentionBMRAdiscussed_in_filing Artificial Intelligence
topic_mentionBMRAdiscussed_in_filing Cybersecurity
topic_mentionBMRAdiscussed_in_filing Trusted Computing
topic_mentionBMRAdiscussed_in_filing Blockchain & Crypto
topic_mentionBMRAdiscussed_in_filing Supply Chain
topic_mentionBMRAdiscussed_in_filing Regulation
topic_mentionBMRAdiscussed_in_filing Healthcare & Bio
topic_mentionBMRAdiscussed_in_filing AI Compute
topic_mentionBMRAdiscussed_in_filing Platform & Ecosystem
topic_mentionBMRAdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-08-292025-05-310001641172-25-026041EDGAR38K words
2024-08-282024-05-310001493152-24-034208EDGAR—
2023-08-252023-05-310001493152-23-030254EDGAR—
2022-08-292022-05-310001513162-22-000114EDGAR—
2021-08-272021-05-310001513162-21-000112EDGAR—
2020-08-312020-05-310001513162-20-000185EDGAR—
2019-08-292019-05-310001513162-19-000194EDGAR—
2018-08-292018-05-310001513162-18-000223EDGAR—
2017-08-292017-05-310001513162-17-000246EDGAR—
2016-08-292016-05-310001513162-16-000987EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-01-142025-11-300001493152-26-002286EDGAR18K words
2025-10-142025-08-310001493152-25-018043EDGAR—
2025-04-142025-02-280001641172-25-004571EDGAR—
2025-01-142024-11-300001493152-25-002209EDGAR—
2024-10-152024-08-310001493152-24-041156EDGAR—
2024-04-122024-02-290001493152-24-014474EDGAR—
2024-01-162023-11-300001493152-24-002331EDGAR—
2023-10-122023-08-310001493152-23-037070EDGAR—
2023-04-142023-02-280001513162-23-000067EDGAR—
2023-01-132022-11-300001513162-23-000005EDGAR—
2022-10-132022-08-310001513162-22-000122EDGAR—
2022-04-142022-02-280001513162-22-000051EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2025-12-160001493152-25-027891EDGAR1K words
2025-10-080001493152-25-017363EDGAR—
2025-06-060001641172-25-013942EDGAR—
2025-04-160001641172-25-004976EDGAR—
2024-12-170001493152-24-050432EDGAR—
2024-11-060001493152-24-043867EDGAR—
2024-06-280001493152-24-025656EDGAR—
2024-05-100001493152-24-018697EDGAR—
2023-12-110001493152-23-044431EDGAR—
2023-09-190001493152-23-033030EDGAR—

193 total filings indexed. 161 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. AWHL — Aspira Women's Health Inc. BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc. IDXX — IDEXX LABORATORIES INC /DE ICCC — IMMUCELL CORP /DE/

Tags

clinical-laboratories point-of-care-testing-(physicians-offices) over-the-counter-home-use gastroenterology international-diagnostics-markets fda-current-good-manufacturing-practices-(cgmp) ce-mark iso-(international-organization-for-standardization) fda-510(k)-clearance

Company Identity

CIK0000073290
TickerBMRA
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedDE
HeadquartersIrvine, California

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 68dba64036bc7d8cdf84d9561db6744681b48633a04246058fc63ef21d3949df
parent: 1a3ed9dc7e9d57952ce4fc6b602283bb7861aaf0dc8d25df31c4df3bb4d2a5bb
content hash: 45a35c18ef8bc55c8591013e4db3424bf3d28414820e2f1da2deee04dca115ac
signed: 2026-04-13T04:44:02.250Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf